A Novel Gene Signature-Based Model Predicts Biochemical Recurrence-Free Survival in Prostate Cancer Patients after Radical Prostatectomy

Currently, decision-making regarding biochemical recurrence (BCR) following prostatectomy relies solely on clinical parameters. We therefore attempted to develop an integrated prediction model based on a molecular signature and clinicopathological features, in order to forecast the risk for BCR and...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Run, Bao, Xuanwen, Weischenfeldt, Joachim, Schaefer, Christian, Rogowski, Paul, Schmidt-Hegemann, Nina-Sophie, Unger, Kristian, Lauber, Kirsten, Wang, Xuanbin, Buchner, Alexander, Stief, Christian, Schlomm, Thorsten, Belka, Claus, Li, Minglun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017310/
https://www.ncbi.nlm.nih.gov/pubmed/31861273
http://dx.doi.org/10.3390/cancers12010001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017310/
https://www.ncbi.nlm.nih.gov/pubmed/31861273
http://dx.doi.org/10.3390/cancers12010001

Ejemplares similares